ArticleInternational journal of hematology2020

Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study.

Ayumu Ito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.